Home
Johannes Jacob Pieter Kastelein, Chief Scientific Officer: NewAmsterdam Pharma NAMS Sell · Filed 02/24
Trade details
- Type
- Insider sale
- Amount
- $1,091,777.94
- Shares · price
- 30,789 sh · $35.46 a share
- Held after
- 53,500 sh
- Trade date
- 26/02/20
- Filed
- 26/02/24
- Days to filing
- 4 days
Sold 36.5% of holdings
- Share of holding sold
- 36.5%
NewAmsterdam Pharma trades, last 26 weeks
What else happened in NewAmsterdam Pharma around then
Filed or reported within 30 days of the trade day · 01/21~03/22Johannes Jacob Pieter Kastelein's recent trades
- Johannes Jacob Pieter Kastelein
Planned sale10b5-1 planNewAmsterdam Pharma
Planned sale10b5-1 planNewAmsterdam Pharma
NAMS
$3.5M
125,000 sh
$3.5M
Filed 08/24
Traded 08/24
- Johannes Jacob Pieter Kastelein
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 planNewAmsterdam Pharma
NAMS
$3.2M
104,467 sh
$3.2M
Filed 03/09
Traded 03/05
- Johannes Jacob Pieter Kastelein
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 planNewAmsterdam Pharma
NAMS
$3.1M
101,409 sh
$3.1M
Filed 03/09
Traded 03/09
- Johannes Jacob Pieter Kastelein
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 planNewAmsterdam Pharma
NAMS
$2.9M
94,124 sh
$2.9M
Filed 03/09
Traded 03/06
- Johannes Jacob Pieter Kastelein
Planned sale10b5-1 planNewAmsterdam Pharma
Planned sale10b5-1 planNewAmsterdam Pharma
NAMS
$9.4M
300,000 sh
$9.4M
Filed 03/05
Traded 03/02